Welcome to LookChem.com Sign In|Join Free
  • or
1H-Imidazole-1-carboxamide, N-(4-chlorophenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

117654-35-0

Post Buying Request

117654-35-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117654-35-0 Usage

Antifungal medication

Clotrimazole is used to treat various fungal infections.

Indications

It is used to treat yeast infections of the skin and vagina, jock itch, and ringworm.

Mechanism of action

Clotrimazole works by disrupting the cell membrane of the fungus, leading to the inhibition of its growth and replication.

Forms

It is available in various forms, including cream, lotion, and solution.

Dosage

It is typically applied to the affected area 2-3 times daily for several weeks, or as directed by a healthcare professional.

Side effects

Common side effects include skin irritation or rash at the application site.

Contraindications

Clotrimazole should not be ingested and is not effective for the treatment of bacterial or viral infections.

Check Digit Verification of cas no

The CAS Registry Mumber 117654-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,6,5 and 4 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 117654-35:
(8*1)+(7*1)+(6*7)+(5*6)+(4*5)+(3*4)+(2*3)+(1*5)=130
130 % 10 = 0
So 117654-35-0 is a valid CAS Registry Number.

117654-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-chlorophenyl)-1H-imidazole-1-carboxamide

1.2 Other means of identification

Product number -
Other names 1-(N-m-chlorophenyl)imidazole-1-carboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:117654-35-0 SDS

117654-35-0Relevant academic research and scientific papers

Design, synthesis and biological evaluation of indole derivatives as novel inhibitors targeting B-Raf kinase

Wu, Zeng,Yan, Ming,Hu, Shi-He,Yu, Zhi-Cheng,Zhu, Yong,Cheng, Ya-Dong,Liu, Hai-Chun,Zhang, Yan-Min,Yao, Si-Hui,Tang, Wei-Fang,Lu, Tao

, p. 351 - 354 (2014/02/14)

A series of novel indole derivatives were designed and synthesized and their inhibitory activity against B-Raf and HepG2 cell were also described. Among them, compounds 7a and 7b exhibited excellent potency, which showed the potential for further research

Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: Kinetics and application

Rawling, Tristan,McDonagh, Andrew M.,Tattam, Bruce,Murray, Michael

experimental part, p. 6065 - 6070 (2012/09/22)

N-Carbamoylimidazoles dissociate in solution to yield imidazole and an isocyanate that may be reacted with another aryl amine to form an unsymmetrical biaryl urea. This paper investigates the reaction kinetics and the influence of electron withdrawing/donating substituents on the reaction of N-carbamoylimidazoles with aniline. The overall reaction mechanism involves two zwitterionic intermediates, formed during dissociation and upon reaction of the liberated isocyanate with aniline. The rate limiting step for the reaction is a base catalysed proton transfer from the second zwitterionic intermediate. Although electron withdrawing substituents on the aryl group hinder dissociation, they significantly increase reaction rates compared to compounds bearing electron donating substituents. The imidazole liberated upon dissociation catalyses the rate determining step so that reactions of dissociated N-carbamoylimidazoles proceed more rapidly than those involving only isocyanates. In addition, the imidazole eliminates the need for anhydrous reaction conditions. The N-carbamoylimidazole methodology was demonstrated by preparing sorafenib, a biaryl urea kinase inhibitor, in good yield and excellent purity.

Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDAC inhibitors

Zhu, Yong,Chen, Xin,Wu, Zeng,Zheng, Yixuan,Chen, Yadong,Tang, Weifang,Lu, Tao

, p. 1723 - 1732 (2013/03/13)

A series of diaryl ether hydroxamic acids were synthesized for the first time and evaluated for the HDAC biology and antiproliferative activity. The structures of these new hydroxamic acids derivatives were confirmed by IR, 1H-NMR and mass spectrum. Some of these compounds showed micro molar activity in the HDAC inhibitory assay and against four cancer cell lines.

Efficient solid-phase synthesis of disubstituted 1,3-dihydro-imidazol-2- ones

Rossé, Gérard,Strickler, Julie,Patek, Marcel

, p. 2167 - 2168 (2007/10/03)

A bromoacetal linker was used to achieve the synthesis of ureas on a solid support. The resulting ureido acetals were treated with TFA and were converted in an intramolecular cyclization via N-acyliminium ion to disubstituted 1,3-dihydro-imidazol-2-ones.

REACTIONS OF ISOTHIOCYANATES AND ISOCYANATES WITH SOME SILYLATED NITROGEN-CONTAINING NUCLEOPHILES

Gonda, Josef,Antalova, Zuzana

, p. 685 - 694 (2007/10/02)

Aryl isothiocyanates and arylisocyanates react with N,O-bis(trimethylsilyl)acetamide to give N-methyl-N'-arylthioureas and ureas.Also nucleophilic additions of other aprotic nucleophiles (e.g.N-trimethylsilylimidazole, N-trimethylsilylpiperidine and N-trimethylsilylmorpholine) to the N=C=X (X=O,S) group were investigated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 117654-35-0